Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy
Authors' conclusion
The FINDRISC scores of 9 and 10 points show the best effectiveness for screening T2D, with moderate and low quality of evidence respectively. Although the cut-off of 12 points has lower sensitivity, it significantly reduces the FPR and increase the specificity with moderate quality of evidence.
Study context
- Population
- Studies of FINDRISC for T2D screening; Embase, Scopus, Medline, WoS and Cochrane, inception to November 202425 cross-sectional, 7 cohort studies
- Comparison
- FINDRISC score vs OGTT for detection of T2D
- Outcome
- Accuracy of FINDRISC vs OGTT for detection of T2D (sensitivity, specificity, summary ROC)
Methodological detailsbivariate hierarchical random effects model, QUADAS-2 risk of bias, GRADE certainty of evidence
- Bivariate hierarchical random effects model
- QUADAS-2 risk of bias
- GRADE certainty of evidence
Pooled result
As reported in the abstract
Diagnostic accuracy of FINDRISC cut-offs 9–15 points vs OGTT for T2D
AUC range
0.694 and 0.755
Sensitivity range
53.1% (95% CI 38.9-66.8) to 84.7% (95% CI 72.7-92.0)
False positive rate range
21.8% (95% CI 12.9-34.3) to 54.8% (95% CI 38.0-70.5)
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy. Diabetes Res Clin Pract. Published 12 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →